platinum has been researched along with Neoplasm Metastasis in 86 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (17.44) | 18.7374 |
| 1990's | 3 (3.49) | 18.2507 |
| 2000's | 2 (2.33) | 29.6817 |
| 2010's | 51 (59.30) | 24.3611 |
| 2020's | 15 (17.44) | 2.80 |
| Authors | Studies |
|---|---|
| Aytes, A; Font, A; Ruiz de Porras, V | 1 |
| Arsenijević, A; Arsenijević, N; Milovanović, J; Milovanović, M; Rajković, S; Vasić, I; Živković, MD | 1 |
| De, A; Deo, AN; Dhadve, AC; Ray, P; Rekhi, B; Thorat, R | 1 |
| Economidou, SC; Fotopoulos, G; Vrontis, K | 1 |
| Chen, Y; Cui, J; Han, J; Li, L; Li, Z; Liu, M; Liu, Z; Wang, Q; Wang, Z; Zhang, N | 1 |
| Chen, C; Ding, SR; Glorieux, C; Huang, P; Huang, ZL; Li, H; Li, XH; Liu, SR; Tao, YL; Wang, GN; Wang, HB; Wei, YH; Wu, YF; Xia, YF; Zheng, SH | 1 |
| Chen, C; Chen, T; Fu, S; He, LN; Hong, S; Li, H; Lin, Z; Wang, Y; Zhang, L; Zhang, X; Zhou, Y | 1 |
| Arkenau, HT; Chu, BC; Klein, AB; Nordstrom, BL; Oguz, M; Ouwens, M | 1 |
| Bas, T; Bischoff, HG; Boyer, M; Cheng, SY; Clingan, P; Dómine, M; Esteban, E; Felip, E; Gadgeel, S; Garassino, MC; Garon, EB; Gray, JE; Grossi, F; Hochmair, MJ; Hui, R; Jennens, RR; Kurata, T; Novello, S; Peled, N; Pietanza, MC; Powell, SF; Reck, M; Rodríguez-Abreu, D; Rubio-Viqueira, B; Speranza, G; Yang, J | 1 |
| Chen, H; Chen, S; Ding, F; Song, H; Xiao, H; Zhang, L | 1 |
| Collette, S; Galsky, MD; Grossfeld, G; Han, GC; Necchi, A; Saci, A; Sharma, P; Siefker-Radtke, A; Szabo, PM | 1 |
| Jiang, G; Kang, J; Li, W; Liu, L; Owusu, L; Wang, J; Wang, X; Xu, X; Zhang, C; Zhang, L; Zhou, L | 1 |
| Balermpas, P; Belka, C; Bergmann, T; Fietkau, R; Göhler, T; Große-Thie, C; Guntinas-Lichius, O; Hahn, D; Hautmann, MG; Hecht, M; Messinger, D; Orlowski, K; Reichert, D; Stenzel, KG; von der Grün, J; Welslau, M; Weniger, S; Wolber, P | 1 |
| Chen, C; Qian, J; Tong, Z; Zhang, Y | 1 |
| Cullen, GD; Goergen, K; Jin, L; Kalogera, E; Oberg, AL; Ray, U; Roy, D; Shridhar, V; Staub, J; Thirusangu, P; Wahner Hendrickson, AE; Xiao, Y | 1 |
| Ramkissoon, S; Sorscher, S | 1 |
| Bozkaya, Y; Demirci, NS; Erdem, GU; Ozdemir, NY; Yazici, O; Zengin, N | 1 |
| Chen, R; Ding, H; Fen, Y; Fu, X; Ji, X; Mao, X; Ren, K; Shan, Y; Wu, X; Zhou, F | 1 |
| Babu, S; Govind Babu, K; Jacob, L; Lakshmaiah, KC; Lokanatha, D; Lokesh, KN; Rajeev, LK; Rudresha, AH; Sridharmurthy, A; Thanky, AH | 1 |
| Behera, D; Lawania, S; Sharma, S; Singh, N | 1 |
| Bijwaard, K; Blumenthal, GM; Donoghue, M; Fan, I; Fiero, MH; Goldberg, KB; Keegan, P; Larkins, E; Lee, EY; Mathieu, L; McKee, A; Odogwu, L; Pazdur, R; Philip, R; Rodriguez, L | 1 |
| Chung, V; Cristea, M; Diamond, DJ; Ellenhorn, JDI; Eng, M; Frankel, P; Hardwick, NR; Kaltcheva, T; Kilpatrick, J; Kos, F; Leong, L; Morgan, R; Ruel, C; Tinsley, R; Tsai, W; Wilczynski, S | 1 |
| Bellmunt, J; Hoffman-Censits, J; Kaiser, C; Pal, SK; Tayama, D; Zheng, H | 1 |
| Cheng, L; Wang, M; Wei, Q; Xiang, J; Yu, A; Zhang, R; Zhang, Z; Zhou, F; Zhu, M | 1 |
| Barbie, DA; Humeniuk, R; Kawashima, J; Kelly, K; Koczywas, M; Kong, S; Spira, A | 1 |
| Goldberg, SB; Herbst, RS | 1 |
| Black-Shinn, J; Boyd, M; Chirovsky, D; Joo, S; Nadler, E | 1 |
| Balmaña, J; Chappey, C; Ettl, J; Fasching, PA; Grischke, EM; Hannah, AL; Hurvitz, SA; Mailliez, A; Mina, LA; Robson, ME; Rugo, HS; Telli, ML; Turner, NC; Wardley, AM | 1 |
| Becker, DJ; Brahmer, JR; Ettinger, DS; Levy, BP; Marrone, KA; Parikh, AB | 1 |
| Li, Y; Li, Z; Lu, L; Xie, X; Xiong, T | 1 |
| Lv, X; Pan, ZH; Su, A; Zhang, J; Zhou, QM | 1 |
| Ganti, AK; West, WW; Zhen, W | 1 |
| Ando, T; Fujinami, H; Horikawa, N; Hosokawa, A; Kajiura, S; Kobayashi, T; Mihara, H; Minemura, M; Nishikawa, J; Note, M; Ogawa, K; Sugiyama, T; Terada, M; Ueda, A; Yabushita, K; Yoshita, H | 1 |
| Goebell, P; Hegele, A; Matz, U; Neuhaus, T | 1 |
| Ashihara, K; Fujiwara, S; Kanemura, M; Kawaguchi, H; Ohmichi, M; Sasaki, H; Takai, M; Tanabe, A; Tanaka, T; Tanaka, Y; Terai, Y; Tsunetoh, S | 1 |
| Allard, A; Bennouna, J; Chadjaa, M; Gorbounova, V; Grossi, F; Kowalski, DM; Reck, M; Rey, A; von Pawel, J | 1 |
| Cohen, EE; Haddad, RI; Licitra, LF; Machiels, JP; Tahara, M | 1 |
| Baez-Revueltas, B; Bouganim, N; Clemons, M; Dent, R; Enright, K; Kassam, F; Khalaf, D; Kiss, A; Myers, J; Peña-Curiel, O; Pritchard, K; Verma, S; Villarreal-Garza, C | 1 |
| Asano, T; Hirohashi, Y; Kuroda, T; Mariya, T; Mizuuchi, M; Saito, T; Sato, N; Sonoda, T; Torigoe, T; Yasuda, K | 1 |
| Ghoneum, A; Gimzewski, JK; Sharma, S; Woo, J; Zabinyakov, N; Zhu, H | 1 |
| Chen, J; Chen, W; Chen, Y; Hu, C; Li, X; Luo, Z; Rajan, N; Wang, Y; Wu, S; Yang, Y | 1 |
| Cai, X; Cheng, Y; Ge, H; Huang, Q; Wang, C; Wang, X; Wang, Y; Xiao, J; Yan, W; Zhang, J; Zhang, Q | 1 |
| Abida, W; Bajorin, DF; Rosenberg, JE | 1 |
| Apollo, A; Bajorin, DF; Bambury, RM; Benjamin, DJ; Chaim, JL; Garcia-Grossman, IR; Iyer, G; Ostrovnaya, I; Regazzi, AM; Rosenberg, JE; Sullivan, J; Voss, MH; Xiao, H; Zabor, EC | 1 |
| Caponigro, F; Clement, PM; Cohen, EE; Cong, XJ; Cupissol, D; de Castro, G; de Souza Viana, L; Del Campo, JM; Ehrnrooth, E; Fayette, J; Gauler, T; Grau, JJ; Guigay, J; Haddad, RI; Keilholz, U; Licitra, LF; Machiels, JP; Tahara, M; Vermorken, JB | 2 |
| Castelo, PS; Garcia-Ruiz, JP; Matesanz Garcia, AI; Souza, AP | 1 |
| Hata, A; Hattori, Y; Imamura, F; Kaneda, T; Katakami, N; Kumagai, T; Morita, S; Negoro, S; Nishimura, T; Nishino, K; Okuda, C; Satouchi, M; Tachihara, M; Urata, Y; Yokota, S | 1 |
| Arai, G; Eto, M; Itoh, K; Kakuma, T; Komatsu, N; Matsueda, S; Matsumoto, K; Moriya, F; Naito, S; Nasu, Y; Noguchi, M; Ohyama, C; Sasada, T; Suekane, S; Tanaka, M; Uemura, H; Yamada, A | 1 |
| Bellmunt, J; Choueiri, TK; Guancial, EA; Kantoff, PW; Lis, RT; Loda, M; Mullane, SA; Rosenberg, J; Stack, EC; Werner, L | 1 |
| Liu, JP | 1 |
| Arrieta, O; Cappuzzo, F; Carter, GC; Ciuleanu, TE; Dakhil, S; Garon, EB; Goksel, T; Karaseva, N; Kim, JH; Kowalyszyn, RD; Lee, P; Lewanski, CR; Park, K; Pérol, M; Pikiel, J; Prabhash, K; Reck, M; Syrigos, KN; Thomas, M; Yurasov, S; Zimmermann, A | 1 |
| Di Palma, M; Guillot, A; Médioni, J; Spaeth, D; Théodore, C | 1 |
| Han, SM; Han, Y; Shi, SB; Tian, J; Wang, YS | 1 |
| Basso, U; Basterretxea, L; Bielle, J; Del Muro, XG; Guillot, A; Houédé, N; Lainez, N; Locker, G; Lucas, C; Lusuardi, L; Morelli, F; Parra, HS; Spaeth, D; Tambaro, R; Theodore, C; Tonini, G | 1 |
| Kang, YK; Lee, CW; Lee, JK; Na, YS; Park, SJ; Park, SR; Park, YS; Ryoo, BY; Ryu, MH; Seo, S | 1 |
| Arranz, JÁ; Azrilevich, A; Baron, A; Bedke, J; Bracarda, S; Galsky, MD; Grimm, MO; Krishnan, S; Lambert, A; Necchi, A; Ohyama, C; Pal, S; Plimack, ER; Qu, X; Retz, M; Saci, A; Sharma, P; Siefker-Radtke, A; Vaena, D | 1 |
| Benasso, M; Erfán, J; Hitt, R; Kawecki, A; Licitra, L; Mesia, R; Remenár, É; Rivera, F; Rottey, S; Senger, S; Störkel, S; Stroh, C; Vermorken, JB; Zabolotnyy, D | 1 |
| Adenis, A; Conroy, T; Gavoille, C | 1 |
| Aso, M; Ekimoto, H; Nakatake, H; Ogawa, A; Suemune, H; Yamaguchi, A | 1 |
| Georgoulias, V; Giannousi, Z; Gioulbasanis, I; Kakalou, D; Makridou, M; Pallis, A; Perdikouri, IE; Vlachostergios, PJ; Xyrafas, A | 1 |
| Bennis, R; Bruce, RH; Das, M; Frankel, P; Hsieh, HB; Liu, X; Ly, JC; Nieva, JJ; Riess, JW; Schwartz, E; Wakelee, HA; Zhou, L | 1 |
| Labianca, R; Merelli, B; Mosconi, S | 1 |
| Hwang, YI; Jang, SH; Jung, KS; Kim, DG; Kim, JH; Kim, SY; Park, S | 1 |
| Chen, Z; Liang, Z; Wang, L; Wang, S; Yang, L; Zeng, S | 1 |
| Bang, YJ; Choi, IS; Han, SW; Im, SA; Kang, EJ; Kim, JH; Kim, JS; Kim, JW; Kim, TY; Kim, YJ; Lee, JS; Lee, KW; Oh, DY | 1 |
| Boku, N; Ebihara, M; Iida, Y; Onitsuka, T; Onozawa, Y; Zenda, S | 1 |
| Einhorn, LH | 1 |
| Buice, RG; Soloway, MS | 1 |
| Crowther, D; Fox, BW; Harrison, R; McAuliffe, CA; Sharma, H; Smith, A; Thatcher, N; Zaki, A | 1 |
| Benjamin, RS; Caprioli, R; Feun, L; Loo, TL; Luna, M; Seifert, W; Stewart, DJ | 1 |
| Plaxe, SC | 1 |
| Desjardins, L; Doz, F; Khelfaoui, F; Michon, J; Mosseri, V; Neuenschwander, S; Quintana, E; Schlienger, P; Validire, P; Vielh, P | 1 |
| Cordier, JF; Trillet-Lenoir, V | 1 |
| Albiol, S; Bellmunt, J | 1 |
| Baumgartner, G; Cannon, PJ; Merrin, C; Wajsman, Z | 1 |
| Baumgartner, G; Merrin, C; Murphy, GP; Takita, H; Wajsman, Z; Weber, R | 1 |
| Donohue, JP; Einhorn, LH | 1 |
| Bellamy, D; Blache, LA; Hinsull, S; Watson, B | 1 |
| Atkinson, N; Castellanos, AM; Choksi, AJ; Dimery, IW; Felder, TB; Hong, WK; McCarthy, K; Newman, RA; Paredes, J; Robbins, KT | 1 |
| Abad-Esteve, A; Fernandez, C; Monras, P; Moreno, I; Morera, J; Ribas-Mundo, M; Rosell, R; Ruiz, J | 1 |
| Gorbunova, VA; Grigorova, TM; Kozachenko, VP; Marenich, AF; Perevodchikova, NI | 1 |
| Mikhael, NZ; Nanji, AA; Stewart, DJ | 1 |
| Evgen'eva, TP | 1 |
| Perlia, CP; Rossof, AH; Slayton, RE | 1 |
| Kociba, RJ; Rosenberg, B; Sleight, SD | 1 |
8 review(s) available for platinum and Neoplasm Metastasis
| Article | Year |
|---|---|
Chemotherapy in metastatic castration-resistant prostate cancer: Current scenario and future perspectives.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; DNA Repair; Drug Resistance, Neoplasm; Humans; Male; Neoplasm Metastasis; Platinum; Prostatic Neoplasms, Castration-Resistant; Taxoids | 2021 |
Current concepts in the management of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Etoposide; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Platinum; Randomized Controlled Trials as Topic; Recurrence; Small Cell Lung Carcinoma; Treatment Outcome | 2013 |
Platinum-based chemotherapy in triple-negative advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Canada; Disease-Free Survival; Electronic Health Records; Female; Humans; Neoplasm Metastasis; Neoplasm Staging; Platinum; Treatment Outcome; Triple Negative Breast Neoplasms | 2014 |
First-line treatment and prognostic factors of metastatic bladder cancer for platinum-eligible patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Neoplasm Metastasis; Platinum; Prognosis; Treatment Outcome; Urinary Bladder Neoplasms | 2015 |
Novel strategies for molecular targeting to cancer.
Topics: Animals; Drug Resistance, Neoplasm; Humans; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasms; Platinum | 2016 |
Metastatic pancreatic cancer: old drugs, new paradigms.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Pancreatic Ductal; Clinical Trials, Phase III as Topic; Deoxycytidine; Erlotinib Hydrochloride; Fluorouracil; Gemcitabine; Heparin; Humans; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Platinum; Quinazolines | 2011 |
[Origin of small cell lung cancers].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Neoplasm Metastasis; Platinum; Podophyllotoxin | 1993 |
New chemotherapy combinations for advanced bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Female; Gemcitabine; Humans; Male; Methotrexate; Neoplasm Metastasis; Platinum; Prognosis; Severity of Illness Index; Survival Analysis; Taxoids; Urinary Bladder Neoplasms; Vinblastine | 2001 |
21 trial(s) available for platinum and Neoplasm Metastasis
| Article | Year |
|---|---|
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pemetrexed; Platinum | 2020 |
Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Transitional Cell; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mutation; Neoplasm Metastasis; Nivolumab; Platinum; Progression-Free Survival; Tumor Burden; Urothelium | 2020 |
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Progression-Free Survival; Proportional Hazards Models; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation.
Topics: Acrylamides; Adult; Aged; Aged, 80 and over; Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; ErbB Receptors; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Metastasis; Platinum; Protein Kinase Inhibitors; Remission Induction; Risk Assessment; United States; United States Food and Drug Administration; Young Adult | 2018 |
p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy.
Topics: Adult; Aged; Cancer Vaccines; Carcinoma, Ovarian Epithelial; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum; T-Lymphocytes; Treatment Outcome; Tumor Suppressor Protein p53 | 2018 |
Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United States.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinoma, Transitional Cell; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Platinum; Prognosis; Risk Assessment; Survival Analysis; Treatment Outcome; United States; Urologic Neoplasms | 2018 |
Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carcinoma, Non-Small-Cell Lung; Female; Humans; Janus Kinases; Lung Neoplasms; Male; MAP Kinase Kinase 1; Middle Aged; Mutation; Neoplasm Metastasis; Platinum; Proto-Oncogene Proteins p21(ras); Pyridones; Pyrimidines; Pyrimidinones; Treatment Failure | 2018 |
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Cohort Studies; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Germ-Line Mutation; Humans; Middle Aged; Neoplasm Metastasis; Phthalazines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Prognosis; Salvage Therapy | 2019 |
A pooled analysis of two phase II trials evaluating metformin plus platinum-based chemotherapy in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Metformin; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum; Prognosis; Treatment Outcome | 2019 |
DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Serine; Taxoids; Treatment Outcome | 2014 |
Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy.
Topics: Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Protocols; Disease Progression; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Retreatment; Squamous Cell Carcinoma of Head and Neck | 2014 |
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Topics: Adult; Afatinib; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2015 |
A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Oxonic Acid; Platinum; Retreatment; Taxoids; Tegafur; Treatment Outcome | 2015 |
An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Combined Modality Therapy; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Platinum; Retreatment; Treatment Outcome; Urinary Bladder Neoplasms; Vaccines, Subunit | 2016 |
Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Platinum; Proportional Hazards Models; Quality of Life; Ramucirumab; Retreatment; Taxoids; Treatment Outcome | 2016 |
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial.
Topics: Afatinib; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Quinazolines; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2016 |
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nivolumab; Platinum; Prognosis; Survival Rate; Urologic Neoplasms | 2017 |
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cetuximab; ErbB Receptors; Fluorouracil; Gene Dosage; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Survival Analysis; Treatment Outcome; Young Adult | 2011 |
Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture.
Topics: Antineoplastic Agents; Bleomycin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Models, Biological; Neoplasm Metastasis; Platinum; Prognosis; Prospective Studies; Random Allocation; Testicular Neoplasms; Vinblastine | 1981 |
Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Ditiocarb; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kidney; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Prospective Studies; Random Allocation | 1988 |
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Podophyllotoxin; Random Allocation | 1987 |
57 other study(ies) available for platinum and Neoplasm Metastasis
| Article | Year |
|---|---|
In vitro and in vivoactivity of series of cationic dinuclearPt(II) complexes.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Ligands; Male; Mice, Inbred BALB C; Molecular Structure; Neoplasm Metastasis; Neoplasms; Platinum | 2021 |
IGF1R-α6 integrin-S100A4 network governs the organ-specific metastasis of chemoresistant epithelial ovarian cancer cells.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Integrin alpha6; Mice; Neoplasm Metastasis; Paclitaxel; Platinum; Receptor, IGF Type 1; S100 Calcium-Binding Protein A4; Signal Transduction | 2022 |
Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Prospective Studies; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2022 |
Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response.
Topics: Animals; Cell Line, Tumor; Coordination Complexes; DNA Damage; Drug Screening Assays, Antitumor; Humans; Inflammation; Ketoprofen; Lymphocytes, Tumor-Infiltrating; Neoplasm Metastasis; Phenylpropionates; Platinum | 2021 |
Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; China; Cohort Studies; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Platinum; Retrospective Studies; Survival Analysis; Treatment Outcome | 2021 |
First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.
Topics: Adenocarcinoma of Lung; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Prognosis; Retrospective Studies; Survival Rate; Taxoids | 2019 |
Effectiveness of durvalumab versus chemotherapy in metastatic urothelial cancer: an observational, indirect comparison.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Therapy; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Platinum; Proportional Hazards Models; Retrospective Studies; Urologic Neoplasms | 2020 |
Enhancing the chemotherapeutic efficacy of platinum prodrug nanoparticles and inhibiting cancer metastasis by targeting iron homeostasis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Coordination Complexes; Drug Carriers; Drug Combinations; Female; Homeostasis; Humans; Iron; Iron Chelating Agents; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Platinum; Prodrugs; Thiosemicarbazones; Xenograft Model Antitumor Assays | 2020 |
Dihydrotanshinone I inhibits ovarian cancer cell proliferation and migration by transcriptional repression of PIK3CA gene.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Furans; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms; Phenanthrenes; Phosphatidylinositol 3-Kinases; Platinum; Proto-Oncogene Proteins c-akt; Quinones; Signal Transduction; Transcription, Genetic; Zebrafish | 2020 |
Immunotherapy vs platinum for advanced or metastatic thymic carcinoma: A protocol for systematic review and meta analysis.
Topics: Antineoplastic Agents; Humans; Immunotherapy; Meta-Analysis as Topic; Neoplasm Metastasis; Platinum; Randomized Controlled Trials as Topic; Systematic Reviews as Topic; Thymoma; Thymus Neoplasms | 2021 |
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization.
Topics: Animals; Autophagy; Cell Proliferation; Cell Survival; CRISPR-Cas Systems; Female; Gene Expression Regulation, Neoplastic; Group III Phospholipases A2; Heterografts; Humans; Lipid Droplets; Lipogenesis; Mice; Microscopy, Electron, Transmission; Neoplasm Metastasis; Ovarian Neoplasms; Platinum; Pyridines; Quinolines | 2021 |
Rapid Progression of Metastatic Pancreatic Adenocarcinoma During Platinum-Based Therapy in a Patient Harboring a Pathogenic BRCA2 Germline Variant.
Topics: Adenocarcinoma; BRCA2 Protein; Disease Progression; Germ-Line Mutation; Humans; Neoplasm Metastasis; Pancreatic Neoplasms; Platinum; United States | 2021 |
5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-Free Survival; Female; Fluorine; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Patient Safety; Platinum; Pyrimidines; Stomach Neoplasms; Taxoids; Treatment Outcome | 2018 |
The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Female; Gene Expression; Humans; Kaplan-Meier Estimate; Male; Membrane Proteins; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum; Prognosis; RNA, Messenger; Stomach Neoplasms; Treatment Outcome | 2017 |
Epidemiology and Outcomes with Platinum-Based Chemotherapy in Recurrent or Metastatic Carcinoma Cervix in a Developing Country: Experience from a Tertiary Oncology Centre in Southern India.
Topics: Developing Countries; Female; Humans; India; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Tertiary Care Centers; Uterine Cervical Neoplasms | 2017 |
Xeroderma pigmentosum complementation group D polymorphism toward lung cancer susceptibility survival and response in patients treated with platinum chemotherapy.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis; Treatment Outcome; Xeroderma Pigmentosum | 2017 |
Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; DNA Repair; Esophageal Squamous Cell Carcinoma; Female; Genetic Association Studies; Genetic Linkage; Genetic Variation; Genotype; Humans; Kaplan-Meier Estimate; Linkage Disequilibrium; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis; Quantitative Trait Loci; Treatment Outcome | 2018 |
Should chemotherapy plus immune checkpoint inhibition be the standard front-line therapy for patients with metastatic non-small cell lung cancer?
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Humans; Lung Neoplasms; Neoplasm Metastasis; Platinum; Standard of Care; Survival Analysis; Treatment Outcome | 2018 |
Treatment patterns and outcomes among patients with recurrent/metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Practice Patterns, Physicians'; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome | 2019 |
In vivo monitoring the process of tumor growth, metastasis and bacterial infection expressing GFP via real-time optical imaging.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Computer Systems; Escherichia coli Infections; Fluorescence; Green Fluorescent Proteins; Humans; Kanamycin; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms; Optical Imaging; Peritoneal Neoplasms; Platinum; Rats; Subcutaneous Tissue | 2013 |
Salvage therapy of gemcitabine plus endostar significantly improves progression-free survival (PFS) with platinum-resistant recurrent epithelial ovarian cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Endostatins; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Prognosis; Recombinant Proteins; Retrospective Studies; Salvage Therapy; Survival Rate | 2013 |
Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinum.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Staging; Platinum; Prognosis; Salvage Therapy; Stomach Neoplasms; Survival Rate | 2013 |
Monotherapy with intravenous vinflunine in patients with advanced or metastatic urothelial cancer after failure of a platinum-containing regimen: a retrospective analysis of German routine data.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Disease Progression; Disease-Free Survival; Female; Germany; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Platinum; Prognosis; Recurrence; Retrospective Studies; Risk; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium; Vinblastine | 2014 |
Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cisplatin; Deoxycytidine; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Ovarian Neoplasms; Platinum; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |
Prognostic impact of human leukocyte antigen class I expression and association of platinum resistance with immunologic profiles in epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens Class I; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Risk Factors | 2014 |
Biophysical and morphological effects of nanodiamond/nanoplatinum solution (DPV576) on metastatic murine breast cancer cells in vitro.
Topics: Animals; Biophysical Phenomena; Cell Line, Tumor; Diamond; Drug Carriers; Mammary Neoplasms, Animal; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Particle Size; Platinum; Pseudopodia | 2014 |
Clinical effectiveness and clinical toxicity associated with platinum-based doublets in the first-line setting for advanced non-squamous non-small cell lung cancer in Chinese patients: a retrospective cohort study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; China; Cohort Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Odds Ratio; Platinum; Registries; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome | 2014 |
Trifolium-like Platinum Nanoparticle-Mediated Photothermal Therapy Inhibits Tumor Growth and Osteolysis in a Bone Metastasis Model.
Topics: Animals; Biocompatible Materials; Body Weight; Bone Neoplasms; Cell Line; Cell Line, Tumor; HeLa Cells; Humans; Imaging, Three-Dimensional; Infrared Rays; Metal Nanoparticles; Mice; Mice, Nude; Microscopy, Electron, Transmission; Neoplasm Metastasis; Neoplasms; NIH 3T3 Cells; Osteolysis; Photochemistry; Phototherapy; Platinum; Platinum Compounds; Povidone; Tomography, X-Ray Computed; Trifolium; X-Ray Microtomography | 2015 |
The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experience.
Topics: Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Clinical Trials as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pemetrexed; Platinum; Prognosis; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium | 2015 |
Thiosemicarbazone-Pt(II) Complex Causes a Growth Inhibitory Effect on Human Mesenchymal Stem Cells.
Topics: Cell Proliferation; Cytoskeleton; Humans; Immunomodulation; Mesenchymal Stem Cells; Models, Molecular; Molecular Conformation; Neoplasm Metastasis; Neovascularization, Pathologic; Organometallic Compounds; Platinum; Thiosemicarbazones | 2015 |
Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma.
Topics: BRCA1 Protein; BRCA2 Protein; Carcinoma, Transitional Cell; DNA Repair; DNA-Binding Proteins; Endonucleases; Fanconi Anemia Complementation Group Proteins; Female; Humans; Male; Membrane Proteins; Neoplasm Metastasis; Neoplasm Proteins; Platinum; Poly (ADP-Ribose) Polymerase-1; Prospective Studies; Rad51 Recombinase; Survival Analysis; Treatment Outcome; Urologic Neoplasms | 2016 |
Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Platinum; Retrospective Studies; Urologic Neoplasms; Urothelium; Vinblastine | 2016 |
Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Esophageal Neoplasms; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum; Retreatment; Survival Analysis; Treatment Outcome; Vinblastine; Vinorelbine | 2016 |
Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy.
Topics: Aged; Aged, 80 and over; Anemia; Disease Progression; Europe; Female; Humans; Kidney Diseases; Liver Neoplasms; Male; Neoplasm Metastasis; Platinum; Practice Guidelines as Topic; Treatment Failure; Urinary Bladder Neoplasms; Urothelium | 2016 |
Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Gene Amplification; Gene Dosage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum; Prognosis; Proportional Hazards Models; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Stomach Neoplasms; Treatment Outcome; Young Adult | 2017 |
Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor.
Topics: Adsorption; Antineoplastic Agents; Bone Neoplasms; Carboplatin; Cell Line, Tumor; Cisplatin; Coordination Complexes; Diphosphonates; Durapatite; Humans; Neoplasm Metastasis; Osteoclasts; Platinum | 2011 |
The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; C-Reactive Protein; Female; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Prognosis; Severity of Illness Index; Treatment Outcome | 2012 |
ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; DNA-Binding Proteins; Endonucleases; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Platinum | 2012 |
Treatment of advanced pancreatic cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Platinum | 2012 |
Timing of chemotherapy-induced neutropenia is a prognostic factor in patients with metastatic non-small-cell lung cancer: a retrospective analysis in gemcitabine-plus-platinum-treated patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Platinum; Prognosis; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2013 |
A novel CD105 determination system based on an ultrasensitive bioelectrochemical strategy with Pt nanoparticles.
Topics: Antigens, CD; Biosensing Techniques; Early Detection of Cancer; Electrochemical Techniques; Endoglin; Humans; Immunoassay; Metal Nanoparticles; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Receptors, Cell Surface | 2012 |
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Camptothecin; Carcinoma, Signet Ring Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Retrospective Studies; Salvage Therapy; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome | 2013 |
Single-agent docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN).
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Tolerance; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Taxoids; Treatment Outcome | 2007 |
Platinum kinetics in patients treated with cis-dichlorodiammine platinum (II).
Topics: Aged; Cisplatin; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged; Neoplasm Metastasis; Platinum; Urinary Bladder Neoplasms | 1982 |
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant disease.
Topics: Aged; Cisplatin; Female; Half-Life; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Organoplatinum Compounds; Platinum; Radioisotopes; Solubility; Time Factors | 1982 |
Human tissue distribution of platinum after cis-diamminedichloroplatinum.
Topics: Autopsy; Cisplatin; Female; Humans; Male; Neoplasm Metastasis; Platinum; Pregnancy; Skin Neoplasms; Spectrometry, X-Ray Emission; Tissue Distribution | 1982 |
Ovarian cancer.
Topics: Female; Humans; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Platinum; Survival Rate; United States | 1994 |
The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Neoplasm Metastasis; Orbital Neoplasms; Platinum; Podophyllotoxin; Retinoblastoma; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 1994 |
Nonhormonal chemotherapy for disseminated renal cell carcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bleomycin; Female; Humans; Kidney Neoplasms; Lomustine; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Platinum | 1976 |
Combination radical surgery and multiple sequential chemotherapy for the treatment of advanced carcinoma of the testis (stage III).
Topics: Adolescent; Adult; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Platinum; Testicular Neoplasms; Vinblastine | 1976 |
Improved chemotherapy in disseminated testicular cancer.
Topics: Bleomycin; Doxorubicin; Drug Therapy, Combination; Humans; Immunotherapy; Male; Neoplasm Metastasis; Platinum; Remission, Spontaneous; Testicular Neoplasms; Vinblastine; Vincristine | 1977 |
Inhibition of the development of Walker 256 carcinoma with a simple metal--plastic implant.
Topics: Animals; Carcinoma 256, Walker; Cell Count; Cell Division; Electrochemistry; Electrons; Foreign Bodies; Male; Mitosis; Neoplasm Metastasis; Platinum; Rats; Rats, Inbred Strains; Silicone Elastomers | 1979 |
[Combined chemotherapy including platinum derivatives in the combined treatment of patients with stage-III to -IV ovarian cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Time Factors | 1986 |
Increase in serum uric acid level associated with cisplatin therapy. Correlation with liver but not kidney platinum concentrations.
Topics: Cisplatin; Humans; Kidney; Liver; Neoplasm Metastasis; Platinum; Time Factors; Uric Acid | 1985 |
[Pigment tumors in rats caused by the implantation of platinum and cellophane films into the eye chamber].
Topics: Animals; Cellophane; Eye Neoplasms; Lens, Crystalline; Melanins; Neoplasm Metastasis; Neoplasms, Experimental; Platinum; Rats; Retina | 1972 |
Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP).
Topics: Amines; Anemia; Antineoplastic Agents; Audiometry; Blood Urea Nitrogen; Bone Marrow; Bone Marrow Cells; Chlorides; Dose-Response Relationship, Drug; Hearing Disorders; Humans; Kidney; Leukopenia; Neoplasm Metastasis; Neoplasms; Platinum; Thrombocytopenia; Time Factors; Uric Acid; Vomiting | 1972 |
Inhibition of Dunning asc itic leukemia and Walker 256 carcinosarcoma with cis-diamminedichloroplatinum (NSC-119875).
Topics: Amines; Animals; Carcinoma 256, Walker; Leukemia, Experimental; Neoplasm Metastasis; Neoplasm Transplantation; Platinum; Rats; Time Factors | 1970 |